Vimarsana
Biggest News Aggregation in the World

Page 6 - Tylenol Cold News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tylenol Cold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tylenol Cold Today - Breaking & Trending Today

WARNING: Alabama Families Will Lose Popular OTC Meds In FDA Ban - Vimarsana News

WARNING: Alabama Families Will Lose Popular OTC Meds In FDA Ban

I have never worried about the basics in life, as much as I do at this point. Medication. All medications should be easy to find when we need them. I've never seen SO MANY drug shortages in Alabama or America in my lifetime.

Source: wtug.com
FDA rules TODAY that Benadryl and Sudafed from pharmacy shelves don't work - Vimarsana News

FDA rules TODAY that Benadryl and Sudafed from pharmacy shelves don't work

The Food and Drug Administration ruled that a common medicine for nasal stuffiness found in common decongestants is ineffective. It is metabolized in the gut and doesn't reach the nose.

A Decongestant in Cold Medicines Doesn't Work at All, an F.D.A. Panel Says - Vimarsana News

A Decongestant in Cold Medicines Doesn't Work at All, an F.D.A. Panel Says

Why It Matters: These Are Popular Staples of the Medicine Cabinet. Every cold and flu season, millions of Americans reach for these products, some over…

Source: biztoc.com
Decongestant in Cold Medicines Doesn't Work, Panel Says - Vimarsana News

Decongestant in Cold Medicines Doesn't Work, Panel Says

The agency now must decide whether products containing the ingredient, like some Sudafed and NyQuil products, should no longer be sold.

Here's Why Many Decongestants May Soon Disappear From Store Shelves - Vimarsana News

Here's Why Many Decongestants May Soon Disappear From Store Shelves

A key ingredient—oral phenylephrine— in cold medications like Benadryl and Mucinex was found ineffective in multiple studies, possibly forcing consumers to turn elsewhere.

Source: forbes.com